English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/177068
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

BCAS2 Enhances Carcinogenic Effects of Estrogen Receptor Alpha in Breast Cancer Cells

AuthorsSalmerón-Hernández, Ángel; Noriega-Reyes, María Yamilet; Jordan, Albert ; Baranda-Avila, Noemi; Langley, Elizabeth
KeywordsEstrogen receptor
Breast cancer
BCAS2
Coactivators
Issue Date22-Feb-2019
PublisherMultidisciplinary Digital Publishing Institute
CitationInternational Journal of Molecular Sciences 20(4): 966 (2019)
AbstractEstrogen receptor alpha (ERα) has an established role in breast cancer biology. Transcriptional activation by ERα is a multistep process modulated by coactivator and corepressor proteins. Breast Cancer Amplified Sequence 2 (BCAS2), is a poorly studied ERα coactivator. In this work, we characterize some of the mechanisms through which this protein increases ERα activity and how this promotes carcinogenic processes in breast cancer cells. Using protein-protein interaction and luciferase assays we show that BCAS2 interacts with ERα both in vitro and in vivo and upregulates transcriptional activation of ERα directly through its N-terminal region (AF-1) and indirectly through its C-terminal (AF-2) region, acting in concert with AF-2 interacting coactivators. Elevated expression of BCAS2 positively affects proliferation, clonogenicity and migration of breast cancer cells and directly activates ERα regulated genes which have been shown to play a role in tumor growth and progression. Finally, we used signal transduction pathway inhibitors to elucidate how BCAS2 is regulated in these cells and observed that BCAS2 is preferentially regulated by the PI3K/AKT signaling pathway. BCAS2 is an AF-1 coactivator of ERα whose overexpression promotes carcinogenic processes, suggesting an important role in the development of estrogen-receptor positive breast cancer.
Publisher version (URL)http://dx.doi.org/10.3390/ijms20040966
URIhttp://hdl.handle.net/10261/177068
DOI10.3390/ijms20040966
ISSN1661-6596
E-ISSN1422-0067
Appears in Collections:(IBMB) Artículos
Files in This Item:
File Description SizeFormat 
ijms-20-00966.pdf3,65 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.